Add to ORKGThe content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the authors or independent peer reviewers. The cornerstone of treatment for early-stage non-small cell lung cancer (NSCLC) has long been surgical resec-tion. Over the past few years, there has been a paradigm shift to provide adjuvant platinum-based chemother-apy for patients with completely resected stage II–IIIA NSCLC founded on large randomized clinical trials demonstrating longer overall survival with this treat
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
For many years, surgery alone was the standard treatment for patients with stage I-IIIA non-small-ce...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
Radical surgery remains the only treatment with curative potential for patients with operable non-sm...
For many years adjuvant chemotherapy has been a standard treatment after complete resection in malig...
Adjuvant chemotherapy for non-small-cell lung carcinoma (NSCLC) is a debated issue in clinical oncol...
Lung cancer is the leading cause of death in the world. Non-small cell lung cancer (NSCLC) represent...
Despite surgical resection, patients with early-stage (I to IIIA) non–small cell lung cancer (NSCLC)...
Abstract:Despite improved surgical techniques, relapse and mortality rates remain high among patient...
Surgery is the primary treatment for patients with stage I, II, or IIIA non-small-cell lung cancer (...
Surgery remains the initial treatment for patients with early-stage non-small cell lung cancer (NSCL...
A significant proportion of patients with non-small cell lung cancer (NSCLC) is diagnosed in the ear...
AbstractCisplatin must be considered the treatment standard for lung cancer chemotherapy, whatever t...
NSCLC, a tobacco-caused disease which is therefore highly preventable, is responsible for about 30% ...
A review of the published clinical trials of surgical adjuvant chemotherapy in lung cancer indicated...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
For many years, surgery alone was the standard treatment for patients with stage I-IIIA non-small-ce...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
Radical surgery remains the only treatment with curative potential for patients with operable non-sm...
For many years adjuvant chemotherapy has been a standard treatment after complete resection in malig...
Adjuvant chemotherapy for non-small-cell lung carcinoma (NSCLC) is a debated issue in clinical oncol...
Lung cancer is the leading cause of death in the world. Non-small cell lung cancer (NSCLC) represent...
Despite surgical resection, patients with early-stage (I to IIIA) non–small cell lung cancer (NSCLC)...
Abstract:Despite improved surgical techniques, relapse and mortality rates remain high among patient...
Surgery is the primary treatment for patients with stage I, II, or IIIA non-small-cell lung cancer (...
Surgery remains the initial treatment for patients with early-stage non-small cell lung cancer (NSCL...
A significant proportion of patients with non-small cell lung cancer (NSCLC) is diagnosed in the ear...
AbstractCisplatin must be considered the treatment standard for lung cancer chemotherapy, whatever t...
NSCLC, a tobacco-caused disease which is therefore highly preventable, is responsible for about 30% ...
A review of the published clinical trials of surgical adjuvant chemotherapy in lung cancer indicated...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
For many years, surgery alone was the standard treatment for patients with stage I-IIIA non-small-ce...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...